Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoChange DetectedA new Study Status entry was added on 2026-07-06 (with a related date marker 2026-07-01 and index 32). An older entry dated 2025-05-13 was removed.SummaryDifference0.3%

- Check12 days agoChange DetectedRevision: v3.6.3 is now listed as the latest revision in the study history, replacing v3.6.2. This indicates a minor update to the page’s revision tracking rather than changes to core study content.SummaryDifference0.1%

- Check19 days agoChange DetectedThe history now includes a new Revision: v3.6.2 entry, replacing v3.6.0, indicating a newer build label applied to the page.SummaryDifference0.1%

- Check33 days agoChange DetectedThe study's history shows the recruitment status changed to no longer looking for participants, signaling that enrollment has ended. The record version advanced to v3.6.0, superseding the previous v3.5.5 entry.SummaryDifference0.3%

- Check40 days agoChange DetectedA new latest revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4). This indicates a minor administrative update to the page rather than substantive changes to the study record.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.5.4 was added to the study's record history, and the previous entry v3.5.3 was removed, reflecting an update to the page's history metadata.SummaryDifference0.1%

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.